Fullerenol nanoparticles suppress RANKL-induced osteoclastogenesis by inhibiting differentiation and maturation
Geng H(耿会); Chang YN(常亚男); Bai X(白雪); Yuan Q(袁卿); Gu WH(古伟宏); Li J(李娟); Chen K(陈奎); Xing GM(邢更妹); Geng, H; Chang, YN
刊名NANOSCALE
2017
卷号9期号:34页码:12516-12523
ISSN号2040-3364
DOI10.1039/c7nr04365a
文献子类Article
英文摘要Bone health requires regulation of homeostatic equilibrium between osteoblasts and osteoclasts. The over-activation of osteoclasts can disrupt bone metabolism, resulting in osteoporosis and other boneloss diseases. Fullerenol, a polyhydroxy derivative of fullerene, exhibits excellent biocompatibility. Here we show that fullerenol nanoparticles exert two functions: inhibition of osteoclastic differentiation and blockage of pre-osteoclast fusion to restructure osteoclast maturation and function. Experimentally, the nanoparticles reduced pre-osteoclast migration and inhibited ruffled border formation to block their maturation. In addition, fullerenol dose-dependently restricted the differentiation of bone marrow macrophage cells (BMMs) to form osteoclasts following treatment with macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor (NF)-kappa B (RANKL) to activate NF-kappa B and mitogen activating protein kinase (MAPK) signaling pathways. It is possible that the very small size of fullerenol allows it to directly cross the cellular membrane to access the cytoplasm and regulate osteoclastogenesis from BMMs. Our results suggest that fullerenol could be used to treat bone-loss diseases such as osteoporosis.
电子版国际标准刊号2040-3372
WOS关键词ACTIN ; BONE ; MECHANISMS ; FUSION ; ORGANIZATION ; ACTIVATION ; PRECURSORS ; MIGRATION ; PODOSOME ; DISEASE
WOS研究方向Chemistry ; Science & Technology - Other Topics ; Materials Science ; Physics
语种英语
WOS记录号WOS:000409215300035
内容类型期刊论文
源URL[http://ir.ihep.ac.cn/handle/311005/285266]  
专题高能物理研究所_多学科研究中心
高能物理研究所_粒子天体物理中心
作者单位中国科学院高能物理研究所
推荐引用方式
GB/T 7714
Geng H,Chang YN,Bai X,et al. Fullerenol nanoparticles suppress RANKL-induced osteoclastogenesis by inhibiting differentiation and maturation[J]. NANOSCALE,2017,9(34):12516-12523.
APA 耿会.,常亚男.,白雪.,袁卿.,古伟宏.,...&Xing, GM.(2017).Fullerenol nanoparticles suppress RANKL-induced osteoclastogenesis by inhibiting differentiation and maturation.NANOSCALE,9(34),12516-12523.
MLA 耿会,et al."Fullerenol nanoparticles suppress RANKL-induced osteoclastogenesis by inhibiting differentiation and maturation".NANOSCALE 9.34(2017):12516-12523.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace